Recent Finacing
Recent Raise
Excalipoint Therapeutics is a Shanghai-based clinical-stage biotechnology company developing T-cell engager (TCE) therapies for cancer and autoimmune diseases.
Focus Areas
Recent Investors
Total Raised
Funding round
